Amlodipine Besylate Tablet
Product Images NDC 71610-691
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 71610-691). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Aphena Pharma Solutions (TN)
Effects-on-primary-endpoint-of-amlodipine (Effects On Primary Endpoint Of Amlodipine)
Kaplan-meier-analysis (Kaplan Meier Analysis)
This text appears to be output from a statistical analysis of an event rate study. It includes values for event rates, a p-value, hazard ratio, and a confidence interval, along with information about the drugs being studied (amlodipine and placebo) and the number of participants at risk. It also includes a time scale in months. However, the text is difficult to interpret without more context or formatting.*
Structural-formula-of-amlodipine-besylate (Structural Formula)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.